01. Historical Context
Allianz in context: 2030 depends more on execution than on rerating
Over the last ten years, ALV.DE traded between roughly EUR 127.8 and EUR 390.5 on monthly closes. The adjusted price series implies a 10-year compound gain of about 16.8%, which is strong enough to warn against lazy extrapolation.
Today's setup is different from the deep-value entry points of the past. Allianz now sits near the top of its historical range, and the debate is less about rescue upside than about how much compounding remains after a good run.
That is why the 2030 discussion should start with current valuation, current capital strength, and the latest operating trend rather than with a backward-looking chart alone.
| Horizon | Latest anchor | Current assessment |
|---|---|---|
| Now | EUR 374.5 share price, 12.02x trailing P/E, 11.60x forward P/E | Neutral to mildly bullish |
| 2026 | EUR 17.4 billion +/- EUR 1.0 billion and 221% Solvency II after 1Q 2026 | Execution year |
| 2030 | Target range depends on claims discipline, capital return, and exit multiple | Base case matters more than rerating hope |
02. Key Forces
Five forces that should drive the next four years
Allianz's first support is operating momentum. Allianz reported 1Q 2026 operating profit of EUR 4.517 billion and a P&C combined ratio of 91.0%.
The second support is capital return. Allianz still carries a strong solvency buffer at 221% and couples that with EUR 2.5 billion buyback. That matters because, at the current multiple, buybacks and dividends remain an important part of total return.
The third support is valuation discipline. A stock trading at 12.02x trailing earnings and 11.60x forward earnings does not look like a momentum bubble, but it also no longer offers the margin of safety of a deeply unloved insurer.
The fourth force is macro transmission. Higher bond yields can support investment income, but sticky inflation can also feed claims costs and keep equity multiples contained. The latest IMF, Eurostat, and ECB data point to slower but still positive growth rather than a clean reacceleration.
The fifth force is strategic execution. For insurers, the stock usually follows the combination of pricing discipline, claims control, capital management, and distribution reach. The market eventually looks through slogans and asks whether those four levers are still working.
| Factor | Latest data | Current Assessment | Bias |
|---|---|---|---|
| Valuation | Trailing P/E 12.02x; forward P/E 11.60x | Reasonable for a large European insurer, not distressed | Neutral to Bullish |
| Operating momentum | 2025 operating profit EUR 17.4 billion; 1Q 2026 operating profit EUR 4.517 billion | Running ahead of a flat macro backdrop | Bullish |
| Underwriting quality | 1Q 2026 P&C combined ratio 91.0% | Still disciplined, but must hold through the next catastrophe cycle | Bullish |
| Capital strength | Solvency II 221%; EUR 2.5 billion buyback | A strong capital base still supports dividends and buybacks | Bullish |
| Macro drag | Euro area CPI 3.0% in April 2026; GDP +0.1% q/q in 1Q 2026 | Higher claims inflation is the main external risk | Neutral |
03. Countercase
What could break the 2030 thesis
The countercase is not that the franchise is weak. It is that the next stage of upside may be capped if inflation, claims pressure, and multiple discipline all tighten at the same time.
That is why the current macro backdrop matters. The IMF now sees euro area growth at 1.1% in 2026, while the ECB still describes the outlook as highly uncertain after a 0.1% first-quarter GDP print.
If operating trends weaken while macro conditions stay noisy, the stock could deliver a much flatter path than a straight-line forecast assumes.
| Risk | Latest data | Break level | Current assessment |
|---|---|---|---|
| Claims inflation | Euro area CPI 3.0% in April 2026; energy 10.9% | If combined ratio moves above 93% | Manageable, but rising |
| Capital buffer | Solvency II at 221% | Below 210% | Comfortable |
| Valuation reset | Shares trade at 12.02x trailing P/E | A de-rating to 10-11x | Real risk if growth softens |
| Asset management cycle | 1Q 2026 third-party net inflows were EUR 45.2 billion | If flows turn negative for several quarters | Healthy today |
04. Institutional Lens
Institutional lens: the data that currently matters most
Allianz's own disclosures set the nearest institutional anchor. The May 13, 2026 release showed 1Q 2026 operating profit of EUR 4.517 billion, core EPS of EUR 9.96, and Solvency II of 221%.
The macro anchor is less comfortable. The IMF cut its 2026 euro area growth view to 1.1% in April 2026, while Eurostat and the ECB both showed inflation pressure picking up again into April.
That leaves current market data as the valuation anchor. At EUR 374.5 and 12.02x trailing P/E, investors are paying for resilience, but not yet for an extreme growth story.
| Source | Updated | What it says | Why it matters |
|---|---|---|---|
| Allianz | May 2026 | Allianz reported EUR 4.517 billion of 1Q 2026 operating profit and kept 2026 guidance intact | Company execution still drives the thesis |
| IMF Europe | April 17, 2026 | The IMF cut its 2026 euro area growth view to 1.1% as energy shock risk rose | Supports a cautious growth backdrop |
| Eurostat | April 30, 2026 | Euro area inflation was 3.0% in April 2026; energy inflation was 10.9% | Claims costs and discount rates remain live issues |
| ECB | Issue 3, 2026 | The ECB noted euro area GDP growth of 0.1% in 1Q 2026 and kept the deposit rate at 2.00% | No hard landing yet, but no easy macro tailwind either |
| Market data | May 15, 2026 | EUR 374.5 share price with 12.02x trailing P/E and 11.60x forward P/E | Valuation is no longer a deep-value story |
05. Scenarios
Probability-weighted paths to 2030
The most practical way to frame Allianz through 2030 is to combine current valuation with a conservative operating path. The base case does not need another decade-like rerating; it only needs the current franchise to keep compounding.
The bull case requires continued earnings delivery plus evidence that the market still rewards European insurers with high capital return and stable solvency. The bear case is mostly a valuation discipline story layered on top of softer operating numbers.
| Scenario | Probability | Trigger | Target range | Review point | Action bias |
|---|---|---|---|---|---|
| Bull | 25% | Core EPS keeps tracking the top end of the 7-9% 2024-2027 target, combined ratio stays near 91-92%, and solvency remains above 215% | EUR 560-650 | Review after FY26 and FY27 results | Add only if the trigger is visible |
| Base | 55% | Operating profit stays around guidance, P&C remains disciplined, and valuation stays around 11.5-13x | EUR 430-520 | Review at each half-year report | Core holding or watchlist |
| Bear | 20% | Combined ratio drifts above 93%, solvency weakens below 210%, or the market de-rates the stock toward 10-11x earnings | EUR 320-370 | Reassess immediately if the trigger appears | Reduce or stay patient |
References
Sources
- Allianz 1Q 2026 earnings release
- Allianz 4Q and 12M 2025 earnings release PDF
- Allianz Capital Markets Day 2024 targets
- Yahoo Finance 10-year chart data for ALV.DE
- Stock Analysis overview for Allianz SE
- Stock Analysis statistics for Allianz SE
- IMF Regional Economic Outlook for Europe, April 2026
- Eurostat flash estimate for euro area inflation, April 2026
- ECB Economic Bulletin Issue 3, 2026